These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 18405471)

  • 1. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
    Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
    Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review.
    Hockenhull JC; Dwan KM; Smith GW; Gamble CL; Boland A; Walley TJ; Dickson RC
    Crit Care Med; 2009 Feb; 37(2):702-12. PubMed ID: 19114884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New choices for central venous catheters: potential financial implications.
    Shorr AF; Humphreys CW; Helman DL
    Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
    Walder B; Pittet D; Tramèr MR
    Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review.
    Niël-Weise BS; Stijnen T; van den Broek PJ
    J Hosp Infect; 2008 Jun; 69(2):114-23. PubMed ID: 18439717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
    Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
    Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
    Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
    Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
    Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
    Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.
    Niël-Weise BS; Stijnen T; van den Broek PJ
    Intensive Care Med; 2007 Dec; 33(12):2058-68. PubMed ID: 17940746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision.
    Halton KA; Cook DA; Whitby M; Paterson DL; Graves N
    Crit Care; 2009; 13(2):R35. PubMed ID: 19284570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of prolonging the use of central venous catheters: a prospective analysis of the effects of using antiseptic-bonded catheters with daily site care.
    Norwood S; Wilkins HE; Vallina VL; Fernandez LG; McLarty JW
    Crit Care Med; 2000 May; 28(5):1376-82. PubMed ID: 10834681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis.
    Casey AL; Mermel LA; Nightingale P; Elliott TS
    Lancet Infect Dis; 2008 Dec; 8(12):763-76. PubMed ID: 19022192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
    Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
    J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
    Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.